Table 1 |
|
Potentially beneficial actions of insulin in critical illness |
|
Less (stress) hyperglycaemia by 'overcoming' insulin resistance, and therefore better antimicrobial defence and wound healing |
|
Stimulation of glucose uptake/glycolysis, pyruvate dehydrogenase and energy production |
|
Anti-inflammatory properties, such as less oxygen radical formation |
|
Suppression of insulin-like growth factor (IGF)-I-binding protein, increased IGF-I |
|
Increased muscle protein synthesis |
|
Inhibition of apoptosis and promoting repair of damaged tissue |
|
Promotion of ischaemic preconditioning |
|
Less ischaemia/reperfusion damage |
|
|
|
Johan Groeneveld et al. Critical Care 2002 6:102 doi:10.1186/cc1463 |